Summit Therapeutics (SMMT.MX) Q4 2024 Earnings

30OctConfirmed
Q3 2024
Q4 2024
-1.35
-1.22
-1.1
-0.98

Details

Expected EPS
-1.3453135149999997
Actual EPS
-1.00765
Surprise EPS
0.34
Surprise Percent
+25.1%

Description

Summit Therapeutics (SMMT.MX) has reported earnings of -1.00765 per share for Q4 2024.

0 Comments

Share your thoughts